Medtecs International Corporation Limited

NT$5.07As of Sun 8 Nov 2026, 12:00 UTC

TWSE:9103Healthcare

Country Taiwan

PE (Fwd) —

TSR 10Y CAGR 11.57%

Div yield —

ROE (4.59%)

Medical Instruments & Supplies

Beta (5Y) 0.82

PE TTM —

TSR TTM 7.87%

Mkt cap NT$2.763B

ROIC (5.70%)

SE Grade™

—

Value

Quality

Moat

1Y Price

Reference

NT$5.46

7.61%

(9.22%)

Price near Reference Value

TTM

FYE 31 Dec USD

FY2022

FY2023

FY2024

FY2025

FY2026E

Trend

10Y

Peers

78.97

Revenue$M

—

56.24

52.64

54.42

78.97

84.38

11.98%

—

45.10

Revenue growth%

—

(6.41)

3.39

45.10

6.85

3.39

—

16.01

Gross margin%

—

(5.93)

11.32

12.65

16.01

17.09

11.98

—

(7.92)

Operating margin%

—

(57.68)

(46.66)

(51.53)

(7.92)

(7.23)

(49.09)

—

(6.03)

Net margin%

—

(50.84)

(40.02)

(41.20)

(6.03)

(5.36)

(40.61)

—

P/E ratio (avg)x

—

EV/EBITx

—

(10.84)

FCF yield (avg)%

—

(9.65)

(11.96)

(0.83)

(9.51)

(11.51)

(9.58)

—

(11.46)

FCF margin%

—

(28.91)

(27.72)

(1.86)

(11.46)

(11.38)

(19.59)

—

1.899

FCF / Net incomex

—

0.569

0.693

0.045

1.899

—

0.631

—

(5.70)

ROIC%

—

(21.45)

(17.23)

(22.85)

(5.70)

(5.53)

(19.34)

—

(4.59)

Return on equity%

—

(19.09)

(15.10)

(19.05)

(4.59)

(4.55)

(17.08)

—

(3.27)

Return on assets%

—

(15.71)

(12.63)

(16.25)

(3.27)

(3.20)

(14.17)

—

(0.01)

EPS$

—

(0.05)

(0.04)

(0.01)

—

78.75

EPS growth%

—

26.28

(6.44)

78.75

5.12

26.28

—

0.19

Bookvalue per sh$

—

0.27

0.24

0.19

0.18

(12.13%)

—

(0.02)

FCF per share$

—

(0.03)

—

(0.02)

—

Dividend per sh$

—

Div yield (avg)%

—

Payout ratio%

—

544.9

Shares (diluted)M

—

545.3

544.9

◌544.9

(0.02%)

—

Buyback yield%

—

0.07

—

◌—

—

0.214

D/E ratiox

—

0.131

0.208

0.210

0.214

0.224

0.209

—

89.63

Enterprise value$M

—

169.8

126.7

127.2

101.3

99.23

(15.82%)

—

LT debt$M

—

Peers (US$43.34M)

Cap (US$)

BenQ Medical Technolog…

54.31M

2.443x

Chi Sheng Pharma…

50.96M

9.188x

Lagis Enterprise Co.…

35.30M

16.36x

DK Life Science Co.…

43.86M

11.95x

Capital

TTM

10Y

Leveragex

15.09

EBIT/Intx

(8.108)

(34.90)

Own earn%

—

Sh yield%

—

Owners

Insiders/Inst%

9.20

3.29

Short interest%

—

SBC / revenue%

—

Record

10Y

Profitable years

0/4

Revenue growth years

2/3

EPS growth years

2/3

Dividend streakyrs

Op margin range%

−58–−8

$1 testx

—

Incr. ROIC%

—

Medtecs International Corporation Limited, an integrated healthcare services provider, manufactures and distributes medical consumables for healthcare distributors, pharmaceutical companies, and hospital groups. It operates through Manufacturing, Hospital, and Distribution and Others segments.

Growth vs revenue

Latest

Trend

3Y CAGR

Rel growth

Revenue

$78.97M

11.98%

1.00×

Cost of revenue

$66.32M

3.64%

0.79×

Operating expenses

$18.90M

(13.41%)

0.46×

Asset mix

Trend

Other

87.41%

Cash and investments

10.64%

Goodwill & intangibles

1.95%

Reinvestment returns

No breakdown available